APO Research

APO RESEARCH · REPORT

Yellow Fever Vaccines

Selected research

Industry Research

Yellow Fever Vaccines Industry Research Report 2026

Market perspective

The global Yellow Fever Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Yellow Fever Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Yellow Fever Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Yellow Fever Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Yellow Fever Vaccines include Bio-Manguinhos, FSUE Chumakov, Institut Pasteur de Dakar and Sanofi Pasteur, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Yellow Fever Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Yellow Fever Vaccines Market by Company

Bio-Manguinhos

FSUE Chumakov

Institut Pasteur de Dakar

Sanofi Pasteur

Yellow Fever Vaccines Segment by Type

Institonal Contributions

Private Purchase

Others

Yellow Fever Vaccines Segment by Application

Routine Immunization

Travelers

Other

Yellow Fever Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Yellow Fever Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Yellow Fever Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Yellow Fever Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Yellow Fever Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Yellow Fever Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Yellow Fever Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Yellow Fever Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Yellow Fever Vaccines Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Yellow Fever Vaccines Sales Market Share by Manufacturers (2021-2026) Table 8. Global Yellow Fever Vaccines Revenue of Manufacturers (2021-2026) Table 9. Global Yellow Fever Vaccines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Yellow Fever Vaccines Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Yellow Fever Vaccines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Yellow Fever Vaccines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Yellow Fever Vaccines, Product Type & Application Table 14. Global Yellow Fever Vaccines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Yellow Fever Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Bio-Manguinhos Company Information Table 19. Bio-Manguinhos Business Overview Table 20. Bio-Manguinhos Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Bio-Manguinhos Yellow Fever Vaccines Product Portfolio Table 22. Bio-Manguinhos Recent Developments Table 23. FSUE Chumakov Company Information Table 24. FSUE Chumakov Business Overview Table 25. FSUE Chumakov Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. FSUE Chumakov Yellow Fever Vaccines Product Portfolio Table 27. FSUE Chumakov Recent Developments Table 28. Institut Pasteur de Dakar Company Information Table 29. Institut Pasteur de Dakar Business Overview Table 30. Institut Pasteur de Dakar Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Institut Pasteur de Dakar Yellow Fever Vaccines Product Portfolio Table 32. Institut Pasteur de Dakar Recent Developments Table 33. Sanofi Pasteur Company Information Table 34. Sanofi Pasteur Business Overview Table 35. Sanofi Pasteur Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Sanofi Pasteur Yellow Fever Vaccines Product Portfolio Table 37. Sanofi Pasteur Recent Developments Table 38. Global Yellow Fever Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 39. Global Yellow Fever Vaccines Sales by Region (2021-2026) & (K Units) Table 40. Global Yellow Fever Vaccines Sales Market Share by Region (2021-2026) Table 41. Global Yellow Fever Vaccines Sales by Region (2027-2032) & (K Units) Table 42. Global Yellow Fever Vaccines Sales Market Share by Region (2027-2032) Table 43. Global Yellow Fever Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 44. Global Yellow Fever Vaccines Revenue Market Share by Region (2021-2026) Table 45. Global Yellow Fever Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 46. Global Yellow Fever Vaccines Revenue Market Share by Region (2027-2032) Table 47. North America Yellow Fever Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 48. North America Yellow Fever Vaccines Sales by Country (2021-2026) & (K Units) Table 49. North America Yellow Fever Vaccines Sales by Country (2027-2032) & (K Units) Table 50. North America Yellow Fever Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 51. North America Yellow Fever Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 52. Europe Yellow Fever Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Europe Yellow Fever Vaccines Sales by Country (2021-2026) & (K Units) Table 54. Europe Yellow Fever Vaccines Sales by Country (2027-2032) & (K Units) Table 55. Europe Yellow Fever Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 56. Europe Yellow Fever Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 57. Asia Pacific Yellow Fever Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Asia Pacific Yellow Fever Vaccines Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Yellow Fever Vaccines Sales by Country (2027-2032) & (K Units) Table 60. Asia Pacific Yellow Fever Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 61. Asia Pacific Yellow Fever Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 62. South America Yellow Fever Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. South America Yellow Fever Vaccines Sales by Country (2021-2026) & (K Units) Table 64. South America Yellow Fever Vaccines Sales by Country (2027-2032) & (K Units) Table 65. South America Yellow Fever Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 66. South America Yellow Fever Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 67. Middle East and Africa Yellow Fever Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Middle East and Africa Yellow Fever Vaccines Sales by Country (2021-2026) & (K Units) Table 69. Middle East and Africa Yellow Fever Vaccines Sales by Country (2027-2032) & (K Units) Table 70. Middle East and Africa Yellow Fever Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 71. Middle East and Africa Yellow Fever Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 72. Global Yellow Fever Vaccines Sales by Type (2021-2026) & (K Units) Table 73. Global Yellow Fever Vaccines Sales by Type (2027-2032) & (K Units) Table 74. Global Yellow Fever Vaccines Sales Market Share by Type (2021-2026) Table 75. Global Yellow Fever Vaccines Sales Market Share by Type (2027-2032) Table 76. Global Yellow Fever Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 77. Global Yellow Fever Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 78. Global Yellow Fever Vaccines Revenue Market Share by Type (2021-2026) Table 79. Global Yellow Fever Vaccines Revenue Market Share by Type (2027-2032) Table 80. Global Yellow Fever Vaccines Price by Type (2021-2026) & (US$/Unit) Table 81. Global Yellow Fever Vaccines Price by Type (2027-2032) & (US$/Unit) Table 82. Global Yellow Fever Vaccines Sales by Application (2021-2026) & (K Units) Table 83. Global Yellow Fever Vaccines Sales by Application (2027-2032) & (K Units) Table 84. Global Yellow Fever Vaccines Sales Market Share by Application (2021-2026) Table 85. Global Yellow Fever Vaccines Sales Market Share by Application (2027-2032) Table 86. Global Yellow Fever Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 87. Global Yellow Fever Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 88. Global Yellow Fever Vaccines Revenue Market Share by Application (2021-2026) Table 89. Global Yellow Fever Vaccines Revenue Market Share by Application (2027-2032) Table 90. Global Yellow Fever Vaccines Price by Application (2021-2026) & (US$/Unit) Table 91. Global Yellow Fever Vaccines Price by Application (2027-2032) & (US$/Unit) Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. Yellow Fever Vaccines Distributors List Table 95. Yellow Fever Vaccines Customers List Table 96. Yellow Fever Vaccines Industry Trends Table 97. Yellow Fever Vaccines Industry Drivers Table 98. Yellow Fever Vaccines Industry Restraints Table 99. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Yellow Fever Vaccines Product Image Figure 5. Global Yellow Fever Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Yellow Fever Vaccines Market Size (2021-2032) & (US$ Million) Figure 7. Global Yellow Fever Vaccines Sales (2021-2032) & (K Units) Figure 8. Global Yellow Fever Vaccines Average Price (US$/Unit) & (2021-2032) Figure 9. Institonal Contributions Product Image Figure 10. Private Purchase Product Image Figure 11. Others Product Image Figure 12. Routine Immunization Product Image Figure 13. Travelers Product Image Figure 14. Other Product Image Figure 15. Global Yellow Fever Vaccines Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Yellow Fever Vaccines, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Yellow Fever Vaccines Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Yellow Fever Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Yellow Fever Vaccines Sales by Region in 2025 Figure 21. Global Yellow Fever Vaccines Revenue by Region in 2025 Figure 22. North America Yellow Fever Vaccines Market Size by Country in 2025 Figure 23. North America Yellow Fever Vaccines Sales Market Share by Country (2021-2032) Figure 24. North America Yellow Fever Vaccines Revenue Market Share by Country (2021-2032) Figure 25. United States Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Yellow Fever Vaccines Market Size by Country in 2025 Figure 28. Europe Yellow Fever Vaccines Sales Market Share by Country (2021-2032) Figure 29. Europe Yellow Fever Vaccines Revenue Market Share by Country (2021-2032) Figure 30. Germany Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Nordic Countries Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Yellow Fever Vaccines Market Size by Country in 2025 Figure 37. Asia Pacific Yellow Fever Vaccines Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Yellow Fever Vaccines Revenue Market Share by Country (2021-2032) Figure 39. China Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Yellow Fever Vaccines Market Size by Country in 2025 Figure 48. South America Yellow Fever Vaccines Sales Market Share by Country (2021-2032) Figure 49. South America Yellow Fever Vaccines Revenue Market Share by Country (2021-2032) Figure 50. Mexico Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Middle East and Africa Yellow Fever Vaccines Market Size by Country in 2025 Figure 54. Middle East and Africa Yellow Fever Vaccines Sales Market Share by Country (2021-2032) Figure 55. Middle East and Africa Yellow Fever Vaccines Revenue Market Share by Country (2021-2032) Figure 56. Turkey Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. UAE Yellow Fever Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Global Yellow Fever Vaccines Sales Market Share by Type (2021-2032) Figure 60. Global Yellow Fever Vaccines Revenue Market Share by Type (2021-2032) Figure 61. Global Yellow Fever Vaccines Price (US$/Unit) by Type (2021-2032) Figure 62. Global Yellow Fever Vaccines Sales Market Share by Application (2021-2032) Figure 63. Global Yellow Fever Vaccines Revenue Market Share by Application (2021-2032) Figure 64. Global Yellow Fever Vaccines Price (US$/Unit) by Application (2021-2032) Figure 65. Yellow Fever Vaccines Value Chain Figure 66. Yellow Fever Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Yellow Fever Vaccines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Institonal Contributions
  • Private Purchase
  • Others
Applications
  • Routine Immunization
  • Travelers
  • Other
Companies covered
  • Bio-Manguinhos
  • FSUE Chumakov
  • Institut Pasteur de Dakar
  • Sanofi Pasteur

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Yellow Fever Vaccines Market Size (2021-2032)
  4. 2.2.2 Global Yellow Fever Vaccines Sales (2021-2032)
  5. 2.2.3 Global Yellow Fever Vaccines Market Average Price (2021-2032)
  6. 2.3 Yellow Fever Vaccines by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Institonal Contributions
  9. 2.3.3 Private Purchase
  10. 2.3.4 Others
  11. 2.4 Yellow Fever Vaccines by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Routine Immunization
  14. 2.4.3 Travelers
  15. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Yellow Fever Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Yellow Fever Vaccines Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Yellow Fever Vaccines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Yellow Fever Vaccines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Yellow Fever Vaccines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Yellow Fever Vaccines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Yellow Fever Vaccines, Product Type & Application
  8. 3.8 Global Manufacturers of Yellow Fever Vaccines, Established Date
  9. 3.9 Global Yellow Fever Vaccines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Bio-Manguinhos
  2. 4.1.1 Bio-Manguinhos Company Information
  3. 4.1.2 Bio-Manguinhos Business Overview
  4. 4.1.3 Bio-Manguinhos Yellow Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Bio-Manguinhos Yellow Fever Vaccines Product Portfolio
  6. 4.1.5 Bio-Manguinhos Recent Developments
  7. 4.2 FSUE Chumakov
  8. 4.2.1 FSUE Chumakov Company Information
  9. 4.2.2 FSUE Chumakov Business Overview
  10. 4.2.3 FSUE Chumakov Yellow Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 FSUE Chumakov Yellow Fever Vaccines Product Portfolio
  12. 4.2.5 FSUE Chumakov Recent Developments
  13. 4.3 Institut Pasteur de Dakar
  14. 4.3.1 Institut Pasteur de Dakar Company Information
  15. 4.3.2 Institut Pasteur de Dakar Business Overview
  16. 4.3.3 Institut Pasteur de Dakar Yellow Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Institut Pasteur de Dakar Yellow Fever Vaccines Product Portfolio
  18. 4.3.5 Institut Pasteur de Dakar Recent Developments
  19. 4.4 Sanofi Pasteur
  20. 4.4.1 Sanofi Pasteur Company Information
  21. 4.4.2 Sanofi Pasteur Business Overview
  22. 4.4.3 Sanofi Pasteur Yellow Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Sanofi Pasteur Yellow Fever Vaccines Product Portfolio
  24. 4.4.5 Sanofi Pasteur Recent Developments
5 Global Yellow Fever Vaccines Market Scenario by Region
  1. 5.1 Global Yellow Fever Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Yellow Fever Vaccines Sales by Region: 2021-2032
  3. 5.2.1 Global Yellow Fever Vaccines Sales by Region: 2021-2026
  4. 5.2.2 Global Yellow Fever Vaccines Sales by Region: 2027-2032
  5. 5.3 Global Yellow Fever Vaccines Revenue by Region: 2021-2032
  6. 5.3.1 Global Yellow Fever Vaccines Revenue by Region: 2021-2026
  7. 5.3.2 Global Yellow Fever Vaccines Revenue by Region: 2027-2032
  8. 5.4 North America Yellow Fever Vaccines Market Facts & Figures by Country
  9. 5.4.1 North America Yellow Fever Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Yellow Fever Vaccines Sales by Country (2021-2032)
  11. 5.4.3 North America Yellow Fever Vaccines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Yellow Fever Vaccines Market Facts & Figures by Country
  15. 5.5.1 Europe Yellow Fever Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Yellow Fever Vaccines Sales by Country (2021-2032)
  17. 5.5.3 Europe Yellow Fever Vaccines Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Yellow Fever Vaccines Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Yellow Fever Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Yellow Fever Vaccines Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Yellow Fever Vaccines Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Yellow Fever Vaccines Market Facts & Figures by Country
  36. 5.7.1 South America Yellow Fever Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Yellow Fever Vaccines Sales by Country (2021-2032)
  38. 5.7.3 South America Yellow Fever Vaccines Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.8 Middle East and Africa Yellow Fever Vaccines Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Yellow Fever Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Yellow Fever Vaccines Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Yellow Fever Vaccines Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Yellow Fever Vaccines Sales by Type (2021-2032)
  2. 6.1.1 Global Yellow Fever Vaccines Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Yellow Fever Vaccines Sales Market Share by Type (2021-2032)
  4. 6.2 Global Yellow Fever Vaccines Revenue by Type (2021-2032)
  5. 6.2.1 Global Yellow Fever Vaccines Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Yellow Fever Vaccines Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Yellow Fever Vaccines Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Yellow Fever Vaccines Sales by Application (2021-2032)
  2. 7.1.1 Global Yellow Fever Vaccines Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Yellow Fever Vaccines Sales Market Share by Application (2021-2032)
  4. 7.2 Global Yellow Fever Vaccines Revenue by Application (2021-2032)
  5. 7.2.1 Global Yellow Fever Vaccines Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Yellow Fever Vaccines Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Yellow Fever Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Yellow Fever Vaccines Value Chain Analysis
  2. 8.1.1 Yellow Fever Vaccines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Yellow Fever Vaccines Production Mode & Process
  5. 8.2 Yellow Fever Vaccines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Yellow Fever Vaccines Distributors
  8. 8.2.3 Yellow Fever Vaccines Customers
9 Global Yellow Fever Vaccines Analyzing Market Dynamics
  1. 9.1 Yellow Fever Vaccines Industry Trends
  2. 9.2 Yellow Fever Vaccines Industry Drivers
  3. 9.3 Yellow Fever Vaccines Industry Opportunities and Challenges
  4. 9.4 Yellow Fever Vaccines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research